European Patent Office revoked Regenlab PRP patent

Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step...

Continue ReadingEuropean Patent Office revoked Regenlab PRP patent

The products shown in this webpage are not cleared by the U.S. FDA for sale in the USA.